GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Regulatory News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report

30 Sep 2019 13:35

RNS Number : 1836O
ABCAM PLC
30 September 2019
 

30 September 2019

ABCAM PLC

("Abcam" or "the Company")

Publication of 2019 Annual Report and Accounts

Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of life science research tools, announces that its Annual Report and Accounts for the year ended 30 June 2019 will be published today on the Company's investor relations website, www.abcamplc.com

It will also be posted today, together with the Notice of Annual General Meeting, to those shareholders that have elected to receive paper communications. Shareholders that have not elected to receive paper communications will be notified of the availability of these documents on the Company's investor relations website, www.abcamplc.com.

For further information please contact:

Abcam plc

+ 44 (0) 1223 696 000

Marc Perkins, Company Secretary

James Staveley, Vice President Investor Relations

 

About Abcam plc

As an innovator in reagents and tools, Abcam's purpose is to serve life science researchers globally to achieve their mission, faster. Providing the research and clinical communities with tools and scientific support, the Group offers highly validated antibodies and assays to address important targets in critical biological pathways.

Already a pioneer in data sharing and ecommerce in the life sciences, Abcam's ambition is to be the most influential company in life sciences by helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health.

Some two-thirds of the world's 750,000 life science researchers use Abcam's antibodies, reagents, biomarkers and assays. By actively listening to and collaborating with these researchers, the Group continuously advances its portfolio to address their needs. A transparent programme of customer reviews and datasheets, combined with an industry-leading validation initiative, gives researchers increased confidence in their results.

Founded in 1998 and headquartered in Cambridge, UK, the Company sells to more than 140 countries. Abcam was admitted to AIM in 2005 (AIM: ABC).

Please visit www.abcam.com or www.abcamplc.com to find out more.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACSCKKDNBBKDBCN
Date   Source Headline
7th Mar 20132:59 pmRNSDirector/PDMR Shareholding
7th Mar 20132:48 pmRNSHolding(s) in Company
6th Mar 20136:16 pmRNSDirector/PDMR Shareholding
5th Mar 20137:00 amRNSInterim Results
5th Mar 20137:00 amRNSHolding(s) in Company
26th Feb 20134:17 pmRNSDirector/PDMR Shareholding
20th Feb 20134:42 pmRNSHolding(s) in Company
12th Feb 20137:00 amRNSNotification of Interim Results
29th Jan 20136:18 pmRNSDirector/PDMR Shareholding
28th Jan 20135:15 pmRNSHolding(s) in Company
22nd Jan 20137:00 amRNSHalf Year Trading Update
15th Jan 20136:12 pmRNSHolding(s) in Company
31st Dec 20127:00 amRNSDirector/PDMR Shareholding
3rd Dec 20125:50 pmRNSTotal Voting Rights
30th Nov 20121:10 pmRNSDirector/PDMR Shareholding
9th Nov 201211:58 amRNSDirector/PDMR Shareholding
5th Nov 20123:14 pmRNSDirector/PDMR Shareholding
2nd Nov 20121:03 pmRNSDirector/PDMR Shareholding
1st Nov 20124:56 pmRNSTotal Voting Rights
29th Oct 201212:01 pmRNSDirector/PDMR Shareholding
22nd Oct 20121:52 pmRNSAGM Statement
22nd Oct 20127:00 amRNSAGM Statement
18th Oct 201212:19 pmRNSHolding(s) in Company
10th Oct 20123:59 pmRNSDirector/PDMR Shareholding
8th Oct 20129:32 amRNSDirector/PDMR Shareholding
4th Oct 20124:14 pmRNSDirector/PDMR Shareholding
2nd Oct 20129:16 amRNSHolding(s) in Company
1st Oct 201212:12 pmRNSHolding(s) in Company
1st Oct 201212:03 pmRNSTotal Voting Rights
28th Sep 201212:19 pmRNSDirector/PDMR Shareholding
28th Sep 201211:45 amRNSHolding(s) in Company
21st Sep 20124:26 pmRNSAnnual Report & Accounts
12th Sep 20126:06 pmRNSHolding(s) in Company
6th Sep 20127:00 amRNSPreliminary Results 2012
30th Aug 20127:00 amRNSNotification of Preliminary Results
28th Aug 20127:00 amRNSPDMR Shareholding
30th Jul 20127:00 amRNSPDMR Shareholding
25th Jul 20127:00 amRNSFull Year Trading Update
2nd Jul 20127:00 amRNSPDMR Shareholding
21st Jun 20124:06 pmRNSHolding(s) in Company
28th May 201211:25 amRNSPDMR Shareholding
16th May 201210:53 amRNSHolding(s) in Company
8th May 201212:36 pmRNSPDMR Shareholding
1st May 20125:15 pmRNSTotal Voting Rights
27th Apr 20125:18 pmRNSPDMR Shareholding
23rd Apr 20125:37 pmRNSDirector Shareholding
20th Apr 20127:00 amRNSCompletion of Tender Offer
2nd Apr 20127:00 amRNSPDMR Shareholding
2nd Apr 20127:00 amRNSTotal Voting Rights
28th Mar 201212:34 pmRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.